| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.2B | $2.9B | $2.3B | $1.9B | $1.7B | $1.5B | $0.3B | $0.4B |
| Cost of Revenue | $0.4B | $0.3B | $0.3B | $0.2B | $0.1B | $0.1B | $0.0B | $0.0B |
| Gross Profit | $2.8B | $2.6B | $2.1B | $1.8B | $1.6B | — | $0.3B | $0.3B |
| R&D Expense | $0.6B | $0.5B | $0.4B | $0.3B | $0.5B | $0.4B | $1.2B | $0.4B |
| SG&A Expense | $0.8B | $0.7B | $0.5B | — | — | — | — | $0.3B |
| Operating Income | $1.5B | $1.4B | $1.2B | $1.0B | $0.6B | $0.6B | $-0.2B | $0.8B |
| Net Income | $1.3B | $1.2B | $1.0B | — | — | — | $-0.1B | $0.6B |
| EPS (Basic) | $30.13 | $26.44 | $21.04 | $15.98 | $10.60 | $11.65 | $1.20 | $1.50 |
| EPS (Diluted) | $27.86 | $24.64 | $19.81 | $15.00 | $10.06 | $11.54 | $1.20 | $1.48 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.9B | $7.4B | $7.2B | $6.0B | $5.2B | $4.6B | $3.9B | $3.4B |
| Current Assets | $3.7B | $3.9B | $3.6B | $3.4B | $2.3B | $2.2B | $1.9B | $1.8B |
| Cash & Equivalents | $1.6B | $1.7B | $1.2B | $1.0B | $0.9B | $0.7B | $0.7B | $0.7B |
| Total Liabilities | $0.8B | $0.9B | $1.2B | $1.2B | $1.2B | $1.2B | $1.1B | $0.6B |
| Current Liabilities | $0.6B | $0.7B | $0.8B | $0.3B | $0.3B | $0.3B | $0.5B | $0.3B |
| Stockholders' Equity | $7.1B | $6.4B | $6.0B | $4.8B | $4.0B | $3.4B | $2.8B | $2.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.6B | $1.3B | $1.0B | $0.8B | $0.6B | $0.8B | $-0.2B | $0.8B |
| Investing Cash Flow | $-0.6B | $0.4B | $-0.7B | $-0.8B | $-0.5B | $-0.7B | $-0.3B | $-0.8B |
| Capital Expenditures | $0.5B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B | $0.2B |
| Financing Cash Flow | $-1.1B | $-1.3B | $-0.0B | $0.1B | $0.0B | $-0.0B | $0.6B | $0.0B |